American Heart Association
Optimizing Use of GLP-1 RA for Cardiometabolic Benefit: New Strategies and Applications
Moderated Digital Poster Session
Population Science Zone, Moderated Digital Poster 11
Nov 10th , 10:45 AM - 12:00 PM
10 : 45 AM
Tirzepatide Reduces the Risk of Major Adverse Cardiovascular Events: An Individual Participant Data Meta-analysis of Phase 3 Randomized Clinical Trials
Aminorroaya Arya, Oikonomou Evangelos, Biswas Dhruva, Jastreboff Ania, Khera Rohan
Final Pr. ID: MP2211
Authors: Aminorroaya Arya, Oikonomou Evangelos, Biswas Dhruva, Jastreboff Ania, Khera Rohan
Keywords: Cardiovascular disease prevention , Overweight and obesity , Outcomes , Personalized Medicine , Epidemiologic methods
10 : 52 AM
Cardiovascular Benefits of GLP-1 Receptor Agonists in Non-Obese Patients With Type 2 Diabetes, Chronic Kidney Disease, or Coronary Artery Disease: A Real-World TriNetX Analysis
Kochkarian Thierry, Ismail Anis, Blakely Pennelope, Hayek Salim
Final Pr. ID: MP2212
Authors: Kochkarian Thierry, Ismail Anis, Blakely Pennelope, Hayek Salim
Keywords: Diabetes (Type II) , Hypertension , Heart disease , Risk Factors , Outcomes
10 : 59 AM
Impact of GLP-1 Analog Use on Clinical Outcomes Following Bariatric Surgery: A Propensity-Matched Retrospective Cohort Study
Khan Abdul Wali, Abumuhfouz Ma'in, Ishaq Muhammad, Ahmad Zeeshan, Asif Talal
Final Pr. ID: MP2213
Authors: Khan Abdul Wali, Abumuhfouz Ma'in, Ishaq Muhammad, Ahmad Zeeshan, Asif Talal
Keywords: Lifestyle , Bariatric surgery , Pharmacology
11 : 06 AM
Comparing Cardiovascular Outcomes in New Users of Oral Semaglutide Versus Other Noninsulin Glucose-Lowering Therapies
Tan Xi, Liang Yuanjie, Zhong Caichen, Xie Lin, Guevarra Mico, Swift Caroline, De Havenon Adam
Final Pr. ID: MP2214
Authors: Tan Xi, Liang Yuanjie, Zhong Caichen, Xie Lin, Guevarra Mico, Swift Caroline, De Havenon Adam
Keywords: Diabetes (Type II) , Cardiovascular disease , Ischemic stroke , Cardiovascular Risk , Atherosclerosis
11 : 13 AM
Glucagon-Like Peptide-1 Receptor Agonists Show Varied Impact on Venous Thromboembolism Risk: A Comprehensive Bayesian Network Meta-Analysis of Randomized Controlled Trials
Khalil Ibrahim, Hossain Md. Imran, Rahman Mohd Turzo, Akter Mst. Mahmuda, Sayed Md Abu, Sarker Pallab
Final Pr. ID: MP2215
Authors: Khalil Ibrahim, Hossain Md. Imran, Rahman Mohd Turzo, Akter Mst. Mahmuda, Sayed Md Abu, Sarker Pallab
Keywords: Pharmacology , Thrombosis , Diabetes Mellitus , Pulmonary embolism , Diabetes (Type II)
11 : 20 AM
SELECT-LIFE: A non-interventional follow-up study investigating the long-term effects of semaglutide in participants from the SELECT trial
Lingvay Ildiko, Deanfield John, De Los Angeles Quiroga Pelaez Maria, Kahn Steven, Lincoff Abraham, Plutzky Jorge, Ross Stine, Weeke Peter, Ryan Donna
Final Pr. ID: MP2216
Authors: Lingvay Ildiko, Deanfield John, De Los Angeles Quiroga Pelaez Maria, Kahn Steven, Lincoff Abraham, Plutzky Jorge, Ross Stine, Weeke Peter, Ryan Donna
Keywords: Obesity , Cardiovascular disease
11 : 27 AM
Tirzepatide Achieves Greater Weight and Blood Pressure Reduction Than Semaglutide in Routine Clinical Practice
Kim Chungsoo, Jastreboff Ania, Krumholz Harlan, Lu Yuan
Final Pr. ID: MP2217
Authors: Kim Chungsoo, Jastreboff Ania, Krumholz Harlan, Lu Yuan
Keywords: Epidemiology , Obesity
11 : 34 AM
Early GLP-1 Receptor Agonist Initiation Reduces Major Cardiac and Renal Events in Older Adults with Type 2 Diabetes Without Prior Cardiovascular or Renal Disease: A Target Trial Emulation
Chi Kuan Yu, Chang Yu, Varrias Dimitrios, Nanna Michael, Nouri Armin, Lee Pei-lun, Hsieh Rebecca, Mangalesh Sridhar, Hu Jiun-ruey, Ezenna Chidubem, Akman Zafer, Romero Acero Laura
Final Pr. ID: MP2218
Authors: Chi Kuan Yu, Chang Yu, Varrias Dimitrios, Nanna Michael, Nouri Armin, Lee Pei-lun, Hsieh Rebecca, Mangalesh Sridhar, Hu Jiun-ruey, Ezenna Chidubem, Akman Zafer, Romero Acero Laura
Keywords: Older population , Diabetes (Type II) , Prevention , Geriatrics , Glucose
11 : 41 AM
Lower Risk of Cardiovascular Events in Patients with Clinical Atherosclerotic Cardiovascular Disease Initiated on Semaglutide 2.4 mg in the Real-world: Results from the SCORE-Clinical ASCVD Study (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity in the Real World – Clinical Atherosclerotic Cardiovascular Disease Population)
Smolderen Kim, Ozer Kerem, Knop Filip, Nanna Michael, Mena-hurtado Carlos, Divino Victoria, Zhao Zhenxiang, Chen Yan, Boland Joanna, Song Jinlin, O Hartaigh Briain, Traina Andrea
Final Pr. ID: MP2219
Authors: Smolderen Kim, Ozer Kerem, Knop Filip, Nanna Michael, Mena-hurtado Carlos, Divino Victoria, Zhao Zhenxiang, Chen Yan, Boland Joanna, Song Jinlin, O Hartaigh Briain, Traina Andrea
Keywords: Cardiovascular Risk , Outcomes , Obesity , Arteriosclerosis
11 : 48 AM
Glucagon-Like Peptide-1 Receptor Agonist Use Is Associated With Lower Risk Of Cardiovascular Event Recurrence Compared With Use Of Bupropion-Naltrexone or Phentermine-Topiramate: A Nationwide Target Trial Emulation Study
Guo Wenxin, Mac Grory Brian, Lusk Jay, Wang Maidou, Shin Jiwon, Li Fan, Obrien Emily, Glover Lashaunta, Bortfeld Kristina, Aymes Shannon, Porter Michael
Final Pr. ID: MP2220
Authors: Guo Wenxin, Mac Grory Brian, Lusk Jay, Wang Maidou, Shin Jiwon, Li Fan, Obrien Emily, Glover Lashaunta, Bortfeld Kristina, Aymes Shannon, Porter Michael
Keywords: Obesity , Prevention , Health promotion , Metabolic syndrome , Epidemiologic methods
10 : 52 AM
Cardiovascular Benefits of GLP-1 Receptor Agonists in Non-Obese Patients With Type 2 Diabetes, Chronic Kidney Disease, or Coronary Artery Disease: A Real-World TriNetX Analysis
Kochkarian Thierry, Ismail Anis, Blakely Pennelope, Hayek Salim
Final Pr. ID: MP2212
Authors: Kochkarian Thierry, Ismail Anis, Blakely Pennelope, Hayek Salim
Keywords: Diabetes (Type II) , Hypertension , Heart disease , Risk Factors , Outcomes
11 : 06 AM
Comparing Cardiovascular Outcomes in New Users of Oral Semaglutide Versus Other Noninsulin Glucose-Lowering Therapies
Tan Xi, Liang Yuanjie, Zhong Caichen, Xie Lin, Guevarra Mico, Swift Caroline, De Havenon Adam
Final Pr. ID: MP2214
Authors: Tan Xi, Liang Yuanjie, Zhong Caichen, Xie Lin, Guevarra Mico, Swift Caroline, De Havenon Adam
Keywords: Diabetes (Type II) , Cardiovascular disease , Ischemic stroke , Cardiovascular Risk , Atherosclerosis
11 : 34 AM
Early GLP-1 Receptor Agonist Initiation Reduces Major Cardiac and Renal Events in Older Adults with Type 2 Diabetes Without Prior Cardiovascular or Renal Disease: A Target Trial Emulation
Chi Kuan Yu, Chang Yu, Varrias Dimitrios, Nanna Michael, Nouri Armin, Lee Pei-lun, Hsieh Rebecca, Mangalesh Sridhar, Hu Jiun-ruey, Ezenna Chidubem, Akman Zafer, Romero Acero Laura
Final Pr. ID: MP2218
Authors: Chi Kuan Yu, Chang Yu, Varrias Dimitrios, Nanna Michael, Nouri Armin, Lee Pei-lun, Hsieh Rebecca, Mangalesh Sridhar, Hu Jiun-ruey, Ezenna Chidubem, Akman Zafer, Romero Acero Laura
Keywords: Older population , Diabetes (Type II) , Prevention , Geriatrics , Glucose
11 : 48 AM
Glucagon-Like Peptide-1 Receptor Agonist Use Is Associated With Lower Risk Of Cardiovascular Event Recurrence Compared With Use Of Bupropion-Naltrexone or Phentermine-Topiramate: A Nationwide Target Trial Emulation Study
Guo Wenxin, Mac Grory Brian, Lusk Jay, Wang Maidou, Shin Jiwon, Li Fan, Obrien Emily, Glover Lashaunta, Bortfeld Kristina, Aymes Shannon, Porter Michael
Final Pr. ID: MP2220
Authors: Guo Wenxin, Mac Grory Brian, Lusk Jay, Wang Maidou, Shin Jiwon, Li Fan, Obrien Emily, Glover Lashaunta, Bortfeld Kristina, Aymes Shannon, Porter Michael
Keywords: Obesity , Prevention , Health promotion , Metabolic syndrome , Epidemiologic methods
11 : 13 AM
Glucagon-Like Peptide-1 Receptor Agonists Show Varied Impact on Venous Thromboembolism Risk: A Comprehensive Bayesian Network Meta-Analysis of Randomized Controlled Trials
Khalil Ibrahim, Hossain Md. Imran, Rahman Mohd Turzo, Akter Mst. Mahmuda, Sayed Md Abu, Sarker Pallab
Final Pr. ID: MP2215
Authors: Khalil Ibrahim, Hossain Md. Imran, Rahman Mohd Turzo, Akter Mst. Mahmuda, Sayed Md Abu, Sarker Pallab
Keywords: Pharmacology , Thrombosis , Diabetes Mellitus , Pulmonary embolism , Diabetes (Type II)
10 : 59 AM
Impact of GLP-1 Analog Use on Clinical Outcomes Following Bariatric Surgery: A Propensity-Matched Retrospective Cohort Study
Khan Abdul Wali, Abumuhfouz Ma'in, Ishaq Muhammad, Ahmad Zeeshan, Asif Talal
Final Pr. ID: MP2213
Authors: Khan Abdul Wali, Abumuhfouz Ma'in, Ishaq Muhammad, Ahmad Zeeshan, Asif Talal
Keywords: Lifestyle , Bariatric surgery , Pharmacology
11 : 41 AM
Lower Risk of Cardiovascular Events in Patients with Clinical Atherosclerotic Cardiovascular Disease Initiated on Semaglutide 2.4 mg in the Real-world: Results from the SCORE-Clinical ASCVD Study (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity in the Real World – Clinical Atherosclerotic Cardiovascular Disease Population)
Smolderen Kim, Ozer Kerem, Knop Filip, Nanna Michael, Mena-hurtado Carlos, Divino Victoria, Zhao Zhenxiang, Chen Yan, Boland Joanna, Song Jinlin, O Hartaigh Briain, Traina Andrea
Final Pr. ID: MP2219
Authors: Smolderen Kim, Ozer Kerem, Knop Filip, Nanna Michael, Mena-hurtado Carlos, Divino Victoria, Zhao Zhenxiang, Chen Yan, Boland Joanna, Song Jinlin, O Hartaigh Briain, Traina Andrea
Keywords: Cardiovascular Risk , Outcomes , Obesity , Arteriosclerosis
11 : 20 AM
SELECT-LIFE: A non-interventional follow-up study investigating the long-term effects of semaglutide in participants from the SELECT trial
Lingvay Ildiko, Deanfield John, De Los Angeles Quiroga Pelaez Maria, Kahn Steven, Lincoff Abraham, Plutzky Jorge, Ross Stine, Weeke Peter, Ryan Donna
Final Pr. ID: MP2216
Authors: Lingvay Ildiko, Deanfield John, De Los Angeles Quiroga Pelaez Maria, Kahn Steven, Lincoff Abraham, Plutzky Jorge, Ross Stine, Weeke Peter, Ryan Donna
Keywords: Obesity , Cardiovascular disease
11 : 27 AM
Tirzepatide Achieves Greater Weight and Blood Pressure Reduction Than Semaglutide in Routine Clinical Practice
Kim Chungsoo, Jastreboff Ania, Krumholz Harlan, Lu Yuan
Final Pr. ID: MP2217
Authors: Kim Chungsoo, Jastreboff Ania, Krumholz Harlan, Lu Yuan
Keywords: Epidemiology , Obesity
10 : 45 AM
Tirzepatide Reduces the Risk of Major Adverse Cardiovascular Events: An Individual Participant Data Meta-analysis of Phase 3 Randomized Clinical Trials
Aminorroaya Arya, Oikonomou Evangelos, Biswas Dhruva, Jastreboff Ania, Khera Rohan
Final Pr. ID: MP2211
Authors: Aminorroaya Arya, Oikonomou Evangelos, Biswas Dhruva, Jastreboff Ania, Khera Rohan
Keywords: Cardiovascular disease prevention , Overweight and obesity , Outcomes , Personalized Medicine , Epidemiologic methods